Warning letter
Cody Laboratories, Inc: warning letter of Apr 7, 2006
FDA warning letter UCM075861 · Denver District Office
Key facts
| Reference number | UCM075861 |
|---|---|
| Company | Cody Laboratories, Inc |
| Subject | Current Good Manufacturing Practices/Active Pharmaceuticals Ingredient/Adulterated |
| Issue date | Apr 7, 2006 |
| Posted date | Apr 7, 2006 |
| Issuing office | Denver District Office |
| Product type | Drugs |
| CFR sections cited | 211.46, 211.68, 211.186, 211.192, 211.67(b), 211.68(a), 211.100(b), 211.186(b)(7), 211.198(a) |
| Country | 3 |
| Inspection city | Cody |
| Inspection ZIP | 82414-9321 |
| Inspection start date | Mar 7, 2005 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: